医学
化学免疫疗法
阿替唑单抗
三阴性乳腺癌
乳腺癌
肿瘤科
内科学
癌症
免疫疗法
彭布罗利珠单抗
出处
期刊：JAMA
[American Medical Association]
日期：2018-12-21
卷期号：320 (24): 2521-2521
被引量：2
标识
DOI：10.1001/jama.2018.20159
摘要
A chemoimmunotherapy combination with the programmed death ligand 1 (PD-L1) inhibitor atezolizumab prolonged progression-free survival in women with metastatic triple-negative breast cancer, an aggressive cancer with poor outcomes, according to a trial in the New England Journal of Medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI
不配.
pcr163
tuanheqi
VDC
HCLonely
嗯哼
Endlessway
8R60d8
36456657
杳鸢
彭于彦祖
寻道图强
乐乐乐乐乐乐
pluto
经竺
秀丽烨霖
prigogin
库昊的假粉丝
Henry
带头大哥
皖公网安备34019202002308
